Clinical Trials Arena on MSN7h
Icon integrates Medidata’s Clinical Data Studio into clinical studies
Icon has begun the integration of Medidata Clinical Data Studio into its clinical studies. This development makes Icon the ...
Icon downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs downgraded Icon (ICLR) to Neutral from Buy with a price target of $200, down from $250. While the firm continues to believe that ...
TMCnet1d
ICON Becomes the First Large Clinical Research Organization to Fully Integrate Medidata Clinical Data Studio, Streamlining Data Management and Review
The integration of Clinical Data Studio into ICON's service offerings helps unlock the full potential of the Medidata Data Experience, merging information from both Medidata and non-Medidata sources, ...
ICON Public Limited Company (ICLR) Slid on Disappointing Earnings
Polen Capital, an investment management company, released its “Polen Global Growth Strategy” fourth-quarter 2024 investor ...
BMJ1mon
ICON 2019: International Scientific Tendinopathy Symposium Consensus: Clinical Terminology
Tears represent a clinical entity for some tendons which is distinct from tendinopathy, and which may require different management to that of tendinopathy. The ICON group defined tears as a ...
Icon adopting Mural Health’s participant management and payments platform
Icon (ICLR) and Mural Health, a clinical trial technology company, announced a partnership to utilize Mural’s participant management and ...